## EMN: Eastman Chemical Company - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 -1.5% below STRENGTH zone (3.0-6.0%); PEG 3.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($56.74)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 3)

**1. Value Fund Dumps $10.1 Million Eastman Chemical Stake as Stock Slump Continues and EBIT Drops 43%**
- Source: The Globe and Mail | 20251204T230744 | Bearish | Relevance: 100%
- Atlantic Investment Management fully exited its position in Eastman Chemical Company (NYSE: EMN) during the third quarter, selling 134,710 shares worth approximately $10.1 million. This decision follows Eastman's significant stock decline of 41% over the past year and an 11% revenue decrease with a 43% drop in EBIT to $188 million. Despite strong operating cash flow and cost-cutting measures, analysts suggest the exit signals investor concerns about the company's performance amidst soft market demand.

**2. Eastman Chemical raises quarterly dividend to $0.84 per share**
- Source: Investing.com | 20251204T214845 | Somewhat-Bullish | Relevance: 100%
- Eastman Chemical Company announced its Board of Directors approved a quarterly dividend increase from $0.83 to $0.84 per share, marking the 16th consecutive year of dividend increases. The dividend will be payable on January 8, 2026, to stockholders of record as of December 15, 2025. This increase demonstrates the company's commitment to shareholder value, despite recent third-quarter 2025 earnings falling slightly below analyst expectations with an EPS of $1.14 and revenue of $2.2 billion.

**3. Eastman Increases Dividend for 16th Consecutive Year**
- Source: Business Wire | 20251204T211645 | Bullish | Relevance: 100%
- Eastman Chemical Company has announced an increase in its quarterly cash dividend from $0.83 to $0.84 per share, marking the 16th consecutive year of dividend increases. The dividend is payable on January 8, 2026, to stockholders of record as of December 15, 2025. This action reaffirms the company's commitment to delivering shareholder value and demonstrates confidence in its ability to achieve consistent earnings and strong cash generation.

**4. Eastman Chemical Co. stock underperforms Thursday when compared to competitors**
- Source: MarketWatch | 20251204T172600 | Somewhat-Bearish | Relevance: 100%
- Eastman Chemical Co.'s stock (EMN) fell by 1.48% to $60.66 on Thursday, underperforming the broader market despite a mixed trading session. The company's shares are now 41.57% below their 52-week high of $103.82, reached on February 18th. This decline occurred while the S&P 500 Index saw a slight rise and the Dow Jones Industrial Average experienced a small drop.

**5. Eastman Chemical Co. stock underperforms Thursday when compared to competitors**
- Source: MarketWatch | 20251204T172600 | Bearish | Relevance: 100%
- Eastman Chemical Co. (EMN) stock fell by 1.48% to $60.66 on Thursday, underperforming its competitors despite a mixed trading session for the broader market. The company's shares closed 41.57% below their 52-week high of $103.82. The S&P 500 Index rose by 0.11%, while the Dow Jones Industrial Average slightly declined by 0.07%.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-11 | Evercore ISI Gr | $70 | $75 | -7% |
| 2025-11-05 | UBS | $73 | $75 | -3% |
| 2025-11-05 | Wells Fargo | $70 | $80 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-11 | Evercore ISI Gr | main | In-Line |
| 2025-11-05 | UBS | main | Buy |
| 2025-11-05 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 11 ($0.08M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.2%)
- Blackrock Inc.: 7.0% (+0.9%)
- State Street Corpora: 5.0% (+24.3%)
- Capital Research Glo: 3.7% (-1.0%)
- Dimensional Fund Adv: 3.5% (+14.4%)

### Key Risks

1. Valuation risk: PEG 3.7x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 17.8% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.74 signals overvaluation risk, limited margin of safety. Forward P/E 9.9x attractive for 13% earnings growth. Analyst sentiment negative (3 target cuts vs 0 raises). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $7.3B |
| Beta | 1.25 |
| 52W Range | $56.11 - $103.82 |
| Short Interest | 5.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.74 |
| Forward P/E | 9.9 |
| Current P/E | 11.2 |
| YoY Growth | 13.4% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 2.2% to -1.5% (-3.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.5pp (needs >3.0% for momentum thesis). Below SMA200 (0.82x), long-term trend not supportive. RSI neutral at 50. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.48% (CS: 37) | Neutral |
| RSI_14 | 50.0 | Neutral |
| MACD Histogram | 0.33 | Bullish |
| vs SMA20 | 1.008x | Above |
| vs SMA50 | 0.994x | Below |
| vs SMA200 | 0.822x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $60.66
- **Stop Loss:** $56.74 (6.5% risk)
- **Target:** $64.58 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 127
- **Position Value:** $7,703.82
- **Portfolio %:** 7.70%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-01-29 (Est: $0.81)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.17 | $1.14 | -2.2% |
| 2025Q2 | $1.75 | $1.60 | -8.7% |
| 2025Q1 | $1.89 | $1.91 | +1.2% |
| 2024Q4 | $1.57 | $1.87 | +18.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*